Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 7, 2022 | Post-IPO Equity | $60M | — | — | — | Detail |
Oct 31, 2022 | Post-IPO Debt | $32.50M | 1 | Sagard Healthcare Royalty Partners | — | Detail |
Apr 4, 2022 | Post-IPO Equity | $1.23M | — | — | — | Detail |
Mar 31, 2022 | Post-IPO Debt | $30M | 1 | Oaktree Capital Management | — | Detail |
May 17, 2021 | Post-IPO Debt | $45M | 1 | Oaktree Capital Management | — | Detail |
May 29, 2020 | Post-IPO Equity | $46M | — | — | — | Detail |
Dec 10, 2019 | Post-IPO Equity | $70M | 1 | — | — | Detail |
Sep 14, 2017 | Post-IPO Equity | $40.30M | 1 | Bain Capital Life Sciences | — | Detail |
Jul 21, 2014 | IPO | $45M | — | — | — | Detail |
Jan 7, 2013 | Series C | $21M | 4 | — | — | Detail |
Dec 19, 2012 | Series Unknown | $11.43M | 1 | — | — | Detail |
May 3, 2009 | Series B | $20M | 4 | — | — | Detail |
Oct 25, 2005 | Series A | $29.40M | 4 | Canaan Partners , Domain Associates , Sofinnova Investments | — | Detail |